BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Stine JG, Argo CK, Pelletier SJ, Maluf DG, Caldwell SH, Northup PG. Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis. World J Hepatol 2017; 9(3): 139-146 [PMID: 28217250 DOI: 10.4254/wjh.v9.i3.139]
URL: https://www.wjgnet.com/1948-5182/full/v9/i3/139.htm
Number Citing Articles
1
Jonathan G. Stine, Jennifer Wang, Puja M. Shah, Curtis K. Argo, Nicolas Intagliata, Andre Uflacker, Stephen H. Caldwell, Patrick G. Northup. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case‐control studyLiver International 2018; 38(1): 94 doi: 10.1111/liv.13500
2
C. Hobeika, M. Ronot, A. Beaufrere, V. Paradis, O. Soubrane, F. Cauchy. Metabolic syndrome and hepatic surgeryJournal of Visceral Surgery 2020; 157(3): 231 doi: 10.1016/j.jviscsurg.2019.11.004
3
Brian L. Shaw, Bill S. Majdalany, Carlos E. Marroquin. Liver Transplantation - Challenges and Opportunities2024;  doi: 10.5772/intechopen.1003845
4
Ivana Mikolasevic, Tajana Filipec-Kanizaj, Maja Mijic, Ivan Jakopcic, Sandra Milic, Irena Hrstic, Nikola Sobocan, Davor Stimac, Patrizia Burra. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?World Journal of Gastroenterology 2018; 24(14): 1491-1506 doi: 10.3748/wjg.v24.i14.1491
5
Mattias Mandorfer, Elmar Aigner, Manfred Cejna, Arnulf Ferlitsch, Christian Datz, Tilmann Gräter, Ivo Graziadei, Michael Gschwantler, Stephanie Hametner-Schreil, Harald Hofer, Mathias Jachs, Alexander Loizides, Andreas Maieron, Markus Peck-Radosavljevic, Florian Rainer, Bernhard Scheiner, Georg Semmler, Lukas Reider, Silvia Reiter, Maria Schoder, Rainer Schöfl, Philipp Schwabl, Vanessa Stadlbauer, Rudolf Stauber, Elisabeth Tatscher, Michael Trauner, Alexander Ziachehabi, Heinz Zoller, Peter Fickert, Thomas Reiberger. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)Wiener klinische Wochenschrift 2023; 135(S3): 493 doi: 10.1007/s00508-023-02229-w
6
Daniel Gaballa, Dmitri Bezinover, Zakiyah Kadry, Elaine Eyster, Ming Wang, Patrick G. Northup, Jonathan G. Stine. Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk IndexLiver Transplantation 2019; 25(12): 1747 doi: 10.1002/lt.25630
7
Peter L. Wang, Vijay Ramalingam, Lauren M. Yang. Portal Vein Thrombosis in Patients with CirrhosisCurrent Hepatology Reports 2024; 23(1): 64 doi: 10.1007/s11901-024-00636-9
8
Andy Liu, Artin Galoosian, Dharmesh Kaswala, Andrew A. Li, Chiranjeevi Gadiparthi, George Cholankeril, Donghee Kim, Aijaz Ahmed. Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the GraftJournal of Clinical and Translational Hepatology 2018; 6(3): 1 doi: 10.14218/JCTH.2018.00010
9
Patrick G. Northup, Juan Carlos Garcia‐Pagan, Guadalupe Garcia‐Tsao, Nicolas M. Intagliata, Riccardo A. Superina, Lara N. Roberts, Ton Lisman, Dominique C. Valla. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology 2021; 73(1): 366 doi: 10.1002/hep.31646
10
Jonathan G. Stine, Blake A. Niccum, Alex N. Zimmet, Nicolas Intagliata, Stephen H. Caldwell, Curtis K. Argo, Patrick G. Northup. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitisClinical and Translational Gastroenterology 2018; 9(3): e140 doi: 10.1038/s41424-018-0002-y
11
Jonathan G. Stine, Ian Schreibman, Seyedehsan Navabi, Mitchell Kang, Jessica Dahmus, Christopher Soriano, Gloriany Rivas, Breianna Hummer, Megan Beyer, Heather Tressler, Scot R. Kimball, Andrew D. Patterson, Kathryn Schmitz, Christopher Sciamanna. Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASHContemporary Clinical Trials Communications 2020; 18: 100560 doi: 10.1016/j.conctc.2020.100560
12
Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic ImplicationsJournal of Clinical and Translational Hepatology 2022; 10(2): 339 doi: 10.14218/JCTH.2021.00268
13
Abdel-Rauf Zeina, Yael Kopelman, Amir Mari, Helal Said Ahmad, Suheil Artul, Ali Sleman Khalaila, Randa Taher, Fernando Zertuche Villannueva, Rabea Safadi, Saif Abu Mouch, Fadi Abu Baker. Pulmonary embolism risk in hospitalized patients with nonalcoholic fatty liver disease: A case-control studyMedicine 2022; 101(45): e31710 doi: 10.1097/MD.0000000000031710
14
Jonathan G. Stine, Ian R. Schreibman, Alison J. Faust, Jessica Dahmus, Benjamin Stern, Christopher Soriano, Gloriany Rivas, Breianna Hummer, Scot R. Kimball, Nate R. Geyer, Vernon M. Chinchilli, Rohit Loomba, Kathryn Schmitz, Christopher Sciamanna. NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASHHepatology 2022; 76(1): 172 doi: 10.1002/hep.32274
15
Waseem Amjad, Zhenghui G. Jiang, Michelle Lai. Metabolic dysfunction-associated steatotic liver disease related cirrhosis and incidence of portal vein thrombosisEuropean Journal of Gastroenterology & Hepatology 2024; 36(8): 1038 doi: 10.1097/MEG.0000000000002800
16
Plessier Aurélie, Maxime Gasperment, Dominique Debray, Emilie Le Beux, Corinne Brault, Isabelle Ollivier-Hourmand, Danielle Dutheil, Anne Leclercq, Julie Devictor, Virginia Hernández-Gea, Rautou Pierre Emmanuel, Odile Goria. Social and medical support initiatives in vascular liver diseases in France, from child to adultClinics and Research in Hepatology and Gastroenterology 2020; 44(4): 466 doi: 10.1016/j.clinre.2020.03.002
17
倩 刘. Research Progress on Etiology of Cirrhosis with Portal Vein ThrombosisAdvances in Clinical Medicine 2020; 10(03): 185 doi: 10.12677/ACM.2020.103030
18
Manus Rugivarodom, Phunchai Charatcharoenwitthaya. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver CirrhosisJournal of Clinical and Translational Hepatology 2020; 9(1): 1 doi: 10.14218/JCTH.2020.00067
19
Michael Schwarz, Caroline Schwarz, Lukas Burghart, Nikolaus Pfisterer, David Bauer, Wolfgang Hübl, Mattias Mandorfer, Michael Gschwantler, Thomas Reiberger, Ashraf Elbahrawy. Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomesPLOS ONE 2023; 18(8): e0290352 doi: 10.1371/journal.pone.0290352
20
Fuat H. Saner, Ecaterina Scarlatescu, Dieter Clemens Broering, Dmitri Bezinover. The Yin and the Yang of Hemostasis in End-Stage Liver DiseaseJournal of Clinical Medicine 2023; 12(17): 5759 doi: 10.3390/jcm12175759
21
Marco Biolato, Mattia Paratore, Luca Di Gialleonardo, Giuseppe Marrone, Antonio Grieco. Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?World Journal of Hepatology 2022; 14(4): 682-695 doi: 10.4254/wjh.v14.i4.682
22
Francisco Capinha, Carlos Noronha Ferreira. Management of Nonmalignant Portal Vein Thrombosis in CirrhosisGE - Portuguese Journal of Gastroenterology 2024; 31(2): 77 doi: 10.1159/000533161
23
Wasim A. Dar, Elise Sullivan, John S. Bynon, Holger Eltzschig, Cynthia Ju. Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanismsLiver International 2019; 39(5): 788 doi: 10.1111/liv.14091
24
The Effect of Obesity on the State of Platelet-plasma Hemostasis in Patients with Essential Hypertension in Combination with Non-alcoholic Fatty Liver DiseaseFamily medicine 2020; (4): 56 doi: 10.30841/2307-5112.4.2020.217657
25
E Pardina, R Ferrer, J Rossell, D Ricart-Jané, K A Méndez-Lara, J A Baena-Fustegueras, A Lecube, J Julve, J Peinado-Onsurbe. Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgeryInternational Journal of Obesity 2017; 41(9): 1388 doi: 10.1038/ijo.2017.115
26
Jonathan G. Stine, Dmitri Bezinover, Zakiyah Kadry. Coronary artery disease in decompensated patients undergoing liver transplantation evaluationLiver Transplantation 2018; 24(7): 976 doi: 10.1002/lt.25064
27
Oana Nicoară-Farcău, Guillem Soy, Marta Magaz, Anna Baiges, Fanny Turon, Angeles Garcia-Criado, Marta Barrufet, Marta Burrel, Virginia Hernández-Gea, Juan Carlos García-Pagán. New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with CirrhosisSeminars in Thrombosis and Hemostasis 2020; 46(06): 673 doi: 10.1055/s-0040-1715473
28
Paras Garg, Barry Harrison, Edward J. Gane. Incident portal vein thrombosis in liver transplant recipients in New Zealand: Predictors of risk and validation of portal vein thrombosis risk index calculatorFrontiers in Transplantation 2022; 1 doi: 10.3389/frtra.2022.1042684
29
Jessica P. E. Davis, Nicolas M. Intagliata. The Critically Ill Cirrhotic Patient2020; : 219 doi: 10.1007/978-3-030-24490-3_12
30
Magnus Holmer, Espen Melum, Helena Isoniemi, Bo‐Göran Ericzon, Maria Castedal, Arno Nordin, Nicolai Aagaard Schultz, Allan Rasmussen, Pål‐Dag Line, Per Stål, William Bennet, Hannes Hagström. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countriesLiver International 2018; 38(11): 2082 doi: 10.1111/liv.13751
31
Gloriany Rivas, Breianna Hummer-Bair, Dmitri Bezinover, Zakiyah Kadry, Jonathan Stine. Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosisBMJ Open Gastroenterology 2021; 8(1): e000683 doi: 10.1136/bmjgast-2021-000683
32
Niccolò Bitto, Vincenzo La Mura, Anna Ludovica Fracanzani, Armando Tripodi. Is non-alcoholic fatty liver disease a prothrombotic risk factor?Bleeding, Thrombosis, and Vascular Biology 2023; 2(2) doi: 10.4081/btvb.2023.81
33
C. Hobeika, M. Ronot, A. Beaufrere, V. Paradis, O. Soubrane, F. Cauchy. Syndrome métabolique et chirurgie hépatiqueJournal de Chirurgie Viscérale 2020; 157(3): 235 doi: 10.1016/j.jchirv.2019.08.004
34
Stefano Ballestri, Mariano Capitelli, Maria Cristina Fontana, Dimitriy Arioli, Elisa Romagnoli, Catia Graziosi, Amedeo Lonardo, Marco Marietta, Francesco Dentali, Giorgio Cioni. Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative ReviewAdvances in Therapy 2020; 37(5): 1910 doi: 10.1007/s12325-020-01307-z
35
Non-Neoplastic Diseases of the Liver2022; : 265 doi: 10.55418/9781933477183-9
36
Mariella Faccia, Maria Elena Ainora, Francesca Romana Ponziani, Laura Riccardi, Matteo Garcovich, Antonio Gasbarrini, Maurizio Pompili, Maria Assunta Zocco. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debateWorld Journal of Gastroenterology 2019; 25(31): 4437-4451 doi: 10.3748/wjg.v25.i31.4437
37
Roberta Stupia, Rosa Lombardi, Filippo Cattazzo, Mirko Zoncapè, Anna Mantovani, Leonardo De Marco, Alessandro Mantovani, Anna Ludovica Fracanzani, David Sacerdoti, Andrea Dalbeni. Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studiesJournal of Thrombosis and Thrombolysis 2023; 57(2): 330 doi: 10.1007/s11239-023-02912-9
38
Sonal Sharma, Jonathan G. Stine, Thomas Verbeek, Dmitri Bezinover. Management of Patients With Non-alcoholic Steatohepatitis Undergoing Liver Transplantation: Considerations for the AnesthesiologistJournal of Cardiothoracic and Vascular Anesthesia 2022; 36(8): 2616 doi: 10.1053/j.jvca.2021.07.020
39
Liana Gheorghe, Speranta Iacob. Alcohol and Alcohol-related Diseases2023; : 837 doi: 10.1007/978-3-031-32483-3_45